HERVaxx (IMU-131) is a B-cell peptide vaccine composed of a fusion of three epitopes (P467) from the extracellular domain of HER2/neu conjugated to the nontoxic diphtheria protein CRM197 with the adjuvant Montanide [261]. This evidence concerns the gene ERBB2 and diphtheria.